• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年前列腺癌

Prostate cancer in the elderly.

作者信息

Heinzer Hans, Steuber Thomas

机构信息

Martini-Klinik, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

出版信息

Urol Oncol. 2009 Nov-Dec;27(6):668-72. doi: 10.1016/j.urolonc.2009.07.015.

DOI:10.1016/j.urolonc.2009.07.015
PMID:19879477
Abstract

Prostate cancer is the most frequent malignancy in men and predominantly in elderly men. The issue of prostate cancer is likely to assume greater importance with progressive aging of the population. With frequent use of PSA testing most patients were diagnosed with localized cancer even in senior adults. Cancer-specific mortality is low in elderly men with prostate cancer and is dependent on the aggressiveness of the tumor. Currently, no established guidelines for the management of prostate cancer in the elderly exist, and treatment of senior adults with localized cancer is not optimal. While elderly men with indolent disease will not benefit from curative treatment, some patients with aggressive cancers will progress if not adequately treated. Comorbidity is the main predictor of life expectancy in the elderly. In everyday clinical practice, treatment decisions are much more influenced by age than by comorbidity. Curative treatment is an effective treatment option for selected elderly with localized prostate cancer. Conversely, most elderly men with prostate cancer received hormonal therapy, although the benefit of hormonal therapy in localized cancer is not clear and is associated with severe toxicities in some patients. In conclusion, there is a need for more risk stratified approaches for the management of prostate cancer in the elderly to avoid unnecessary intervention in men who unlikely benefit from such intervention, and allow treatment in those who might benefit from it.

摘要

前列腺癌是男性中最常见的恶性肿瘤,主要发生在老年男性中。随着人口的不断老龄化,前列腺癌问题可能会变得更加重要。由于频繁使用前列腺特异性抗原(PSA)检测,即使在老年人中,大多数患者也被诊断为局限性癌症。前列腺癌老年男性的癌症特异性死亡率较低,且取决于肿瘤的侵袭性。目前,尚无针对老年人前列腺癌管理的既定指南,对局限性癌症老年患者的治疗并不理想。虽然患有惰性疾病的老年男性无法从根治性治疗中获益,但一些侵袭性癌症患者若未得到充分治疗将会进展。合并症是老年人预期寿命的主要预测因素。在日常临床实践中,治疗决策受年龄的影响远大于合并症。根治性治疗是部分局限性前列腺癌老年患者的有效治疗选择。相反,大多数前列腺癌老年男性接受了激素治疗,尽管激素治疗在局限性癌症中的益处尚不明确,且在一些患者中会伴有严重毒性。总之,需要更多风险分层方法来管理老年人前列腺癌,以避免对不太可能从此类干预中获益的男性进行不必要的干预,并使可能从中获益的患者得到治疗。

相似文献

1
Prostate cancer in the elderly.老年前列腺癌
Urol Oncol. 2009 Nov-Dec;27(6):668-72. doi: 10.1016/j.urolonc.2009.07.015.
2
Management of localized prostate cancer in senior adults: the crucial role of comorbidity.老年男性局限性前列腺癌的管理:合并症的关键作用
BJU Int. 2008 Mar;101 Suppl 2:16-22. doi: 10.1111/j.1464-410X.2007.07487.x.
3
Decision analyses in consideration of treatment strategies for patients with biochemical failure after curative therapy on clinically localized prostate cancer in the prostate-specific antigen era.在前列腺特异性抗原时代,针对临床局限性前列腺癌根治性治疗后生化复发患者治疗策略的决策分析
Jpn J Clin Oncol. 2007 Oct;37(10):763-74. doi: 10.1093/jjco/hym105. Epub 2007 Oct 22.
4
Gleason score 7 screen-detected prostate cancers initially managed expectantly: outcomes in 50 men.最初采用观察等待策略管理的Gleason评分为7分的筛查发现的前列腺癌:50例男性患者的结局
BJU Int. 2009 Jun;103(11):1472-7. doi: 10.1111/j.1464-410X.2008.08281.x. Epub 2009 Jan 19.
5
Evaluating localized prostate cancer and identifying candidates for focal therapy.评估局限性前列腺癌并确定聚焦治疗的候选者。
Urology. 2008 Dec;72(6 Suppl):S12-24. doi: 10.1016/j.urology.2008.10.004.
6
Elderly and prostate cancer screening.老年人与前列腺癌筛查。
Urol J. 2011 Spring;8(2):83-7.
7
Prostate cancer update: 2007.前列腺癌最新进展:2007年
Curr Opin Oncol. 2008 May;20(3):294-9. doi: 10.1097/CCO.0b013e3282f8b075.
8
[Surgical and medical treatment for localized prostate cancer].[局限性前列腺癌的手术及药物治疗]
Gan To Kagaku Ryoho. 2007 Jul;34(7):1002-5.
9
Incidence of initial local therapy among men with lower-risk prostate cancer in the United States.美国低风险前列腺癌男性患者初始局部治疗的发生率。
J Natl Cancer Inst. 2006 Aug 16;98(16):1134-41. doi: 10.1093/jnci/djj308.
10
Early detection of prostate cancer. Decreasing the mortality rate.前列腺癌的早期检测。降低死亡率。
Minn Med. 1996 Apr;79(4):46-9.

引用本文的文献

1
Association between Charlson comorbidity index and survival outcomes in patients with prostate cancer: A meta-analysis.查尔森合并症指数与前列腺癌患者生存结局的关联:一项荟萃分析。
Heliyon. 2024 Feb 3;10(4):e25728. doi: 10.1016/j.heliyon.2024.e25728. eCollection 2024 Feb 29.
2
Novel Specific Pyruvate Kinase M2 Inhibitor, Compound 3h, Induces Apoptosis and Autophagy through Suppressing Akt/mTOR Signaling Pathway in LNCaP Cells.新型特异性丙酮酸激酶M2抑制剂化合物3h通过抑制LNCaP细胞中的Akt/mTOR信号通路诱导细胞凋亡和自噬。
Cancers (Basel). 2022 Dec 30;15(1):265. doi: 10.3390/cancers15010265.
3
Differences in Prostate Cancer Transcriptomes by Age at Diagnosis: Are Primary Tumors from Older Men Inherently Different?
前列腺癌转录组学的年龄差异:老年男性的原发肿瘤是否存在固有差异?
Cancer Prev Res (Phila). 2022 Dec 1;15(12):815-825. doi: 10.1158/1940-6207.CAPR-22-0212.
4
Effect of the Pandemic on Quality-of-Life Data Collection in Prostate Cancer Patients.疫情对前列腺癌患者生活质量数据收集的影响。
Clinicoecon Outcomes Res. 2021 Nov 18;13:937-941. doi: 10.2147/CEOR.S321638. eCollection 2021.
5
Prostate cancer screening among elderly men in Brazil: should we diagnose or not?巴西老年男性的前列腺癌筛查:我们应该诊断还是不诊断?
Int Braz J Urol. 2020 Jan-Feb;46(1):34-41. doi: 10.1590/S1677-5538.IBJU.2019.0022.
6
Impact of GAS5 genetic polymorphism on prostate cancer susceptibility and clinicopathologic characteristics.GAS5 基因多态性对前列腺癌易感性及临床病理特征的影响。
Int J Med Sci. 2019 Sep 20;16(11):1424-1429. doi: 10.7150/ijms.38080. eCollection 2019.
7
Radical Prostatectomy in Korean Men Aged 75-Years or Older: Safety and Efficacy in Comparison with Patients Aged 65-69 Years.75岁及以上韩国男性的根治性前列腺切除术:与65-69岁患者相比的安全性和有效性
J Korean Med Sci. 2016 Jun;31(6):957-62. doi: 10.3346/jkms.2016.31.6.957. Epub 2016 Apr 25.
8
Geriatric considerations in the treatment of advanced prostate cancer.晚期前列腺癌治疗中的老年医学考量
F1000Prime Rep. 2014 May 6;6:33. doi: 10.12703/P6-33. eCollection 2014.
9
Challenges of managing elderly men with prostate cancer.管理老年前列腺癌男性患者的挑战。
Nat Rev Clin Oncol. 2014 Jun;11(6):354-64. doi: 10.1038/nrclinonc.2014.71. Epub 2014 May 13.
10
Quality of Life and Sexual Health in the Aging of PCa Survivors.前列腺癌幸存者老龄化过程中的生活质量与性健康
Int J Endocrinol. 2014;2014:470592. doi: 10.1155/2014/470592. Epub 2014 Mar 17.